Development of new antibacterials: a laudable aim, but what is the value?
Tillotson
Glenn S
GS
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology*; D055808:Drug Discovery / Q000191:economics* / Q000379:methods / Q000639:trends*; D024881:Drug Resistance, Bacterial; D006291:Health Policy; D006801:Humans
D000900:Anti-Bacterial Agents